Saturday 17 October 2026
Export RCEL’s income statement to Excel — free account
Avita Medical Inc.
RCEL Healthcare Medical Devices
Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 17.8%, EPS grew 33.8%, free cash flow grew 66.5% and total debt rose 10.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
13.04
0.37
−2.76%
Follow RCEL
| Jun '19 | Dec '19 | Jun '20 | Dec '20 | Jun '21 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | — | 2 | 3 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 1.12 | 0.87 | 1.07 | 0.23 | 0.34 | 0.26 | 0.07 |
Altman Z-Score |
42.97 | 1,404.38 | (1.94) | 16.65 | (0.43) | 13.90 | (2.98) | (3.15) | (7.16) | (11.96) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(12.52) | (23.16) | 2.05 | (2.12) | 11.12 | 9.47 | 1.17 | (4.60) | (16.38) | (32.20) |
Beneish M-Score |
— | — | — | — | — | — | 0.20 | (3.01) | (2.03) | (4.09) |
P/Operating CF |
0.00 | (9.98) | (5.24) | (3.54) | (6.38) | 1.96 | (2.35) | (1.58) | (2.05) | (0.88) |
P/B ratio |
0.00 | 0.50 | 0.43 | 0.34 | 0.22 | 0.14 | 0.10 | 0.35 | 3.68 | 0.00 |
Price to Tangible BV |
0.00 | 0.50 | 0.43 | 0.34 | 0.22 | 0.14 | 0.10 | 0.35 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | (2.11) | (2.85) | (4.98) | (2.04) | (0.62) | 0.37 | 0.99 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 1.16 | 5.36 | 4.95 | 2.70 | 0.93 | 0.00 | 0.00 |
EV/Operating CF |
0.45 | 2.44 | 3.33 | 2.82 | 26.22 | 12.64 | 3.69 | 0.82 | (0.49) | (2.28) |
EV/FCF |
0.43 | 2.34 | 3.29 | 2.64 | 22.23 | 12.34 | 3.57 | 0.79 | (0.41) | (2.15) |
Quick Ratio |
5.09 | 5.09 | 9.89 | 9.90 | 16.01 | 16.08 | 7.83 | 7.33 | 2.36 | 0.44 |
Current Ratio |
5.50 | 5.50 | 10.17 | 10.17 | 16.42 | 16.42 | 8.18 | 7.88 | 2.83 | 0.57 |
Net Debt/EBITDA |
0.83 | 0.65 | 1.78 | 1.56 | 4.30 | 4.03 | 3.01 | 1.47 | (0.11) | (0.60) |
Debt/Assets |
0.15% | 0.15% | 0.00% | 2.98% | 0.00% | 1.26% | 0.93% | 35.66% | 53.00% | 76.22% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.01 | 0.01 | 0.81 | 9.39 | (2.58) |
Asset Turnover |
0.25 | 0.21 | 0.26 | 0.17 | 0.28 | 0.23 | 0.31 | 0.48 | 0.67 | 1.05 |
Operating CF/Net income |
0.79 | 0.78 | 0.54 | 0.54 | 0.97 | 0.97 | 0.72 | 1.07 | 0.79 | 0.64 |
Capex/Depreciation |
(4.77) | 0.00 | (1.82) | 0.00 | (1.64) | (0.09) | (0.92) | (2.19) | (8.14) | (0.70) |
Interest Coverage |
(920.36) | (192.77) | (1,272.52) | (2,824.55) | (1,205.59) | (3,364.12) | (1,663.31) | (29.90) | (10.53) | (8.71) |
| (138.34%) | (117.92%) | (90.09%) | (58.05%) | (28.27%) | (22.98%) | (26.61%) | (52.89%) | (230.96%) | 799.72% | |
| (114.36%) | (96.61%) | (77.66%) | (50.97%) | (25.57%) | (21.18%) | (23.83%) | (33.71%) | (64.64%) | (71.40%) | |
ROIC |
(1,478.09%) | 0.00% | 0.00% | 0.00% | (352.10%) | (142.98%) | (263.35%) | 0.00% | (324.79%) | (334.18%) |
Return on Tangible Assets |
(114.83%) | (118.91%) | (58.34%) | (56.50%) | (23.04%) | (22.74%) | (34.20%) | (38.17%) | (131.98%) | 261.83% |
Average Days of Receivables |
141.17 | 138.52 | 62.24 | 64.16 | 92.44 | 98.43 | 46.80 | 56.01 | 66.95 | 46.31 |
Research and Development Expense of Revenue |
186.39% | 186.39% | 64.25% | 59.32% | 50.69% | 50.69% | 40.26% | 41.52% | 31.69% | 29.10% |
Selling, General and Administrative Expense of Revenue |
463.54% | 462.84% | 341.66% | 346.59% | 126.78% | 126.78% | 131.44% | 130.88% | 142.24% | 112.43% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.10 |
Share Based Compensation of Revenue |
35.31% | 0.00% | 115.59% | 0.00% | 19.38% | 12.27% | 20.33% | 16.72% | 21.01% | 13.29% |
Graham Net Nets |
0.00 | 1.90 | 2.20 | 2.77 | 4.37 | 5.41 | 9.17 | 2.41 | (1.10) | (7.81) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 96.85 |
Earnings Yield |
(18.40%) | (12.64%) | (21.84%) | (149.45%) | (91.83%) | (118.44%) | (330.73%) | (205.63%) | (373.39%) | (1,011.00%) |
Free Cash Flow Yield |
0.00% | (40.73%) | (39.88%) | (71.08%) | (14.69%) | (37.74%) | (244.34%) | (229.89%) | (352.21%) | (687.12%) |
Revenue per Share |
0.43 | 0.02 | 14.05 | 0.70 | 25.78 | 1.29 | 27.54 | 39.58 | 49.65 | 51.41 |
Operating CF per Share |
(1.55) | (0.08) | (22.41) | (1.12) | (22.85) | (1.14) | (15.27) | (30.00) | (37.82) | (22.39) |
Capex per Share |
(0.10) | 0.00 | (0.83) | 0.00 | (1.04) | (0.01) | (0.42) | (1.09) | (7.09) | (1.18) |
Free Cash Flow per Share |
(1.65) | (0.08) | (23.25) | (1.12) | (23.88) | (1.15) | (15.69) | (31.09) | (44.91) | (23.57) |
Cash per Share |
1.64 | 0.08 | 72.75 | 3.64 | 97.86 | 4.89 | 63.47 | 70.29 | 27.73 | 13.05 |
Shareholders Equity per Share |
1.71 | 0.08 | 71.33 | 3.57 | 102.02 | 5.10 | 67.79 | 38.72 | 3.48 | (11.95) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.71 | 0.08 | 71.33 | 3.57 | 102.02 | 5.10 | 67.79 | 38.72 | 3.48 | (11.95) |
Free Cash Flow |
(20.94) | (19.66) | (23.59) | (22.75) | (27.07) | (26.03) | (19.61) | (39.39) | (58.11) | (32.83) |
Working Capital |
20.24 | 19.86 | 70.68 | 70.68 | 113.94 | 113.94 | 76.77 | 90.81 | 36.84 | (27.19) |
Capital Expenditures |
(1.28) | (1.28) | (0.85) | (0.85) | (1.17) | (0.13) | (0.52) | (1.38) | (9.17) | (1.64) |
Net Current Asset Value |
20.20 | 19.39 | 68.33 | 68.33 | 111.48 | 111.48 | 73.93 | 41.42 | (18.21) | (37.55) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.86 | 3.14 | 4.83 | 2.64 | 0.91 | 0.00 | 0.00 |
Capex to Sales |
0.23 | 0.00 | 0.06 | 0.00 | 0.04 | 0.00 | 0.02 | 0.03 | 0.14 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.20 | 0.21 | 0.34 | 0.26 | 0.49 | 0.49 | 0.47 | 0.34 | 0.11 | 0.27 |
Cash ROIC |
(49.26%) | (47.62%) | (16.13%) | (15.30%) | (11.95%) | (11.41%) | (11.89%) | (22.14%) | (70.33%) | (73.76%) |
Accounts Receivable Turnover |
1.79 | 2.61 | 6.31 | 5.78 | 5.90 | 3.82 | 5.60 | 8.28 | 6.60 | 6.86 |
Accounts Payable Turnover |
0.57 | 0.54 | 1.24 | 0.69 | 1.60 | 1.91 | 1.97 | 2.29 | 1.80 | 1.68 |
Inventory Turnover |
1.51 | 1.62 | 3.18 | 2.64 | 4.29 | 3.61 | 3.20 | 2.02 | 1.41 | 1.80 |
Average Days of Payables |
1,211.09 | 143.27 | 531.97 | 531.97 | 191.43 | 191.43 | 181.38 | 177.95 | 252.62 | 255.59 |
Days of Inventory on Hand |
227.39 | 223.14 | 138.12 | 138.12 | 101.05 | 101.05 | 128.39 | 262.54 | 291.75 | 197.59 |
Average Receivables |
3.07 | 2.11 | 2.26 | 2.47 | 4.96 | 7.64 | 6.15 | 6.05 | 9.74 | 10.44 |
Average Payables |
2.12 | 2.25 | 2.40 | 4.33 | 3.73 | 3.12 | 3.06 | 3.40 | 5.04 | 7.63 |
Average Inventory |
0.81 | 0.75 | 0.93 | 1.13 | 1.39 | 1.65 | 1.89 | 3.86 | 6.43 | 7.10 |
Average Assets |
21.64 | 26.03 | 54.12 | 82.46 | 103.98 | 125.50 | 111.88 | 104.95 | 95.68 | 68.05 |
Average Common Equity |
17.89 | 21.32 | 46.65 | 72.40 | 94.03 | 115.66 | 100.20 | 66.90 | 26.78 | (6.08) |
Columns are period end dates